Novartis Investigative Site
Boulogne-sur-Mer 62321
0 studies enrolling now · 1 studies all time
What they study most
Non-Hodgkin's Lymphoma
Studies at this site
Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy
— Stopped early